Denne side blev automatisk oversat, og nøjagtigheden af ​​oversættelsen er ikke garanteret. Der henvises til engelsk version for en kildetekst.

Personalized and Scalable Cognitive Remediation Approaches

11. september 2020 opdateret af: Alice Medalia, New York State Psychiatric Institute
The purpose of this study is to develop and pilot test personalized and scalable approaches to Cognitive Remediation (CR) for schizophrenia and schizoaffective disorder. The intent is to more clearly define the therapeutic targets important to the facilitation of cognitive and functional improvement so that clinicians know how to customize cognitive interventions and deliver treatment in a more effective, efficient and personally relevant manner.

Studieoversigt

Status

Afsluttet

Detaljeret beskrivelse

There are three phases of this study.

Phase 1: Development and Adaptation. The goal of this phase is to adapt currently used computer based CR approaches to make them more personalized and scalable. We will create two CR interventions which differ in choice and pacing of the cognitive exercises. This phase is complete.

Phase 2: Open Trial and Intervention Refinement. The goal of this phase is to obtain quantitative and qualitative feedback on the acceptability and usability of the interventions from participants to inform further refinement of the assessment and treatment packages. We will recruit ten subjects from an outpatient psychiatric rehabilitation program in New York City. After determining study eligibility, individuals will complete a standardized neuropsychological battery for schizophrenia assessment, and a 5-minute Tone Matching Test to assess basic auditory processing. Participants will be randomly assigned to receive one of two intervention packages, developed in Phase 1. Each session includes 60 minutes of computer-based learning activities and a 15 minute therapist-led discussion that links the computer activities to cognition as applied to daily tasks and recovery goals. Participants will complete a total of 10 sessions attending 2-3 times weekly for 5 weeks. During each session, participants will be asked to keep a log of software used. At the conclusion of this abbreviated trial, the participants will participate in focus groups in which they will be asked to provide verbal feedback on how enjoyable, engaging, and useful they perceived the computer and discussion based exercises to be. Participants will be asked to provide verbal feedback on the assessment procedures. CR clinicians will join the research team to discuss participants' engagement and their experience with administering the Tone Matching Test and interventions. Qualitative data summarized from participant logs and focus groups will be considered by the research team to refine the assessment battery, treatment parameters, and rubric of learning exercises. This phase is complete.

Phase 3: Pilot Feasibility Trial. People with a diagnosis of schizophrenia or schizoaffective disorder may be referred by their treating clinician or may respond to posted advertisements to inquire about study participation. After being informed of study procedures, interested individuals will be asked to sign a consent form that documents willingness to participate in this study. Following informed consent, participants will be asked questions about demographic characteristics (e.g. age, education, employment), medication and psychosocial treatment status, psychiatric symptoms and symptoms severity, and will complete a brief assessment of estimated Intelligence. Those with an Intelligence Quotient (IQ) estimate below 70 or meeting substance dependence criteria at the time of evaluation will be exited from the study. In the same or second assessment session, participants will complete assessments of neuropsychological ability, current functioning, and motivation for treatment. Participants will then be randomly assigned to one of two treatment conditions named "Brain Basics" or "Brain Exercises".

Each treatment condition is structured in a group format of up to 5 participants. Both treatments use commercially available computer-based training software to exercise cognitive skills such as speed of processing, attention, working memory, and verbal memory. Both conditions will entail 50 minutes on the computer and 10 minutes group discussion. In the discussion, participants review the cognitive activities they are working on and how they will help them achieve their recovery goals. The treatment phase will consist of 30 separate sessions each 60 minutes in duration, administered 3 times a week over the course of a 10-week period. Participants will be re-tested on outcome measures approximately 1 week following end of treatment, and again 3 months later.

Undersøgelsestype

Interventionel

Tilmelding (Faktiske)

122

Fase

  • Ikke anvendelig

Kontakter og lokationer

Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.

Studiesteder

    • New York
      • Bronx, New York, Forenede Stater, 10467
        • FEGS Bronx Mental Health Clinic
      • Brooklyn, New York, Forenede Stater, 11206
        • Williamsburg Clinic
      • Brooklyn, New York, Forenede Stater, 11207
        • Institute for Community Living
      • New York, New York, Forenede Stater, 10032
        • Nyspi/ Cumc
      • New York, New York, Forenede Stater, 10040
        • The Bridge Inc

Deltagelseskriterier

Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.

Berettigelseskriterier

Aldre berettiget til at studere

18 år til 65 år (Voksen, Ældre voksen)

Tager imod sunde frivillige

Ingen

Køn, der er berettiget til at studere

Alle

Beskrivelse

Inclusion Criteria:

  1. Diagnostic and Statistical Manual-IV (DSM-IV) diagnosis of schizophrenia or schizoaffective disorder
  2. Age 18 to 65
  3. English speaking
  4. Psychiatrically stable, verified by current living/treatment status

Exclusion Criteria:

  1. Indication of mental retardation, determined by estimated IQ of less than 70
  2. Hearing or visual impairment that precludes completing assessments
  3. Neurologic illness that may affect brain physiology (e.g. Parkinson's, seizure disorder, epilepsy)
  4. Current substance dependence symptoms in the past 6 weeks
  5. Participation in cognitive remediation in the 12 months prior to study entry.

Studieplan

Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.

Hvordan er undersøgelsen tilrettelagt?

Design detaljer

  • Primært formål: Behandling
  • Tildeling: Randomiseret
  • Interventionel model: Parallel tildeling
  • Maskning: Enkelt

Våben og indgreb

Deltagergruppe / Arm
Intervention / Behandling
Aktiv komparator: Brain Basics for Impaired Tone Matchers
Cognitive remediation includes sensory processing training
Cognitive remediation sessions include working on computer based cognitive exercises and participating in a verbal discussion.
Aktiv komparator: Brain Basics for Intact Tone Matchers
Cognitive remediation includes sensory processing training
Cognitive remediation sessions include working on computer based cognitive exercises and participating in a verbal discussion.
Aktiv komparator: Brain Training for Impaired Tone Matcher
Cognitive remediation does not include sensory processing training
Cognitive remediation sessions include working on computer based cognitive exercises and participating in a verbal discussion.
Aktiv komparator: Brain Training for Intact Tone Matchers
Cognitive remediation does not include sensory processing training
Cognitive remediation sessions include working on computer based cognitive exercises and participating in a verbal discussion.

Hvad måler undersøgelsen?

Primære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
Feasibility
Tidsramme: Two years
Feasibility of conducting a larger trial will be measured by recruitment, feasibility of enrollment, stratification, blinding and assessment, acceptability of randomization, retention of subjects
Two years

Sekundære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
Change in neurocognition from baseline to treatment end-point
Tidsramme: 10 weeks
Change in neurocognition will be measured with the MATRICS Consensus Cognitive Battery, including measures of: a) working memory; b) attention/vigilance; c) verbal learning; d) visual learning; e) processing speed; f) reasoning and problem solving.
10 weeks
Change in neurocognition from baseline to 3-month follow-up
Tidsramme: 5.5 to 6 months
Change in neurocognition will be measured with the MATRICS Consensus Cognitive Battery (see above).
5.5 to 6 months

Andre resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
Tone Matching Ability - Treatment end-point
Tidsramme: 10 weeks
Tone matching (percent correct) will be assessed at baseline and at treatment end-point, using pairs of 100-ms tones in series, with 500-ms inter-tone interval.
10 weeks
UCSD Performance-Based Skills Assessment (UPSA)-Brief - treatment end-point
Tidsramme: 10 weeks
The UPSA - Brief is a proxy measure of daily functioning skills. Change from baseline to treatment end-point will be assessed.
10 weeks
Structured Clinical Interview for the Positive and Negative Syndrome Scale (SCI-PANSS) - Treatment end-point
Tidsramme: 10 weeks
The SCI-PANSS is a semi-structured interview containing 30 items that assess symptoms of psychotic disorders including positive, negative and general psychopathology. Change from baseline to treatment end-point will be assessed.
10 weeks
Intrinsic Motivation Inventory for Schizophrenia Research (IMI-SR)
Tidsramme: 10 weeks
Intrinsic Motivation Inventory for Schizophrenia Research (IMI-SR), a 21 item 7-point Likert type scale designed to assess a participant's subjective experience of an activity, specifically in an experimental setting (e.g. "I enjoyed doing this activity very much"). The IMI-SR will be administered at the first and last treatment sessions.
10 weeks
Perceived Competency Scale (PCS)
Tidsramme: 10 weeks
The PCS consists of 4 items on a 7-point Likert-type scale that assess feelings of competency when performing computer-based learning activities, with higher scores indicating greater perceived competency. The PCS will be administered at the first and last treatment sessions.
10 weeks
Tone Matching ability - 3-month follow up
Tidsramme: 5.5 to 6 months
Tone Matching (percent correct) will be assessed at baseline and 3-month follow-up, using pairs of 100-ms tones in series, with 500-ms inter-tone interval.
5.5 to 6 months
UCSD Performance-Based Skills Assessment (UPSA)-Brief - 3-month follow-up
Tidsramme: 5.5 to 6 months
The UPSA-Brief is a proxy measure for daily functioning skills. Change from baseline to 3-month follow-up will be assessed.
5.5 to 6 months
Structured Clinical Interview for the Positive and Negative Syndrome Scale (SCI-PANSS) - 3-month follow-up
Tidsramme: 5.5 to 6 months
The SCI-PANSS is a semi-structured interview containing 30 items that assess symptoms of psychotic disorders including positive, negative and general psychopathology. Change from baseline to 3-month follow-up will be assessed.
5.5 to 6 months

Samarbejdspartnere og efterforskere

Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.

Efterforskere

  • Ledende efterforsker: Alice Medalia, PhD, NYSPI

Publikationer og nyttige links

Den person, der er ansvarlig for at indtaste oplysninger om undersøgelsen, leverer frivilligt disse publikationer. Disse kan handle om alt relateret til undersøgelsen.

Datoer for undersøgelser

Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.

Studer store datoer

Studiestart

1. september 2013

Primær færdiggørelse (Faktiske)

2. oktober 2017

Studieafslutning (Faktiske)

20. marts 2019

Datoer for studieregistrering

Først indsendt

13. september 2013

Først indsendt, der opfyldte QC-kriterier

13. september 2013

Først opslået (Skøn)

18. september 2013

Opdateringer af undersøgelsesjournaler

Sidste opdatering sendt (Faktiske)

16. september 2020

Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier

11. september 2020

Sidst verificeret

1. september 2020

Mere information

Begreber relateret til denne undersøgelse

Andre undersøgelses-id-numre

  • #6721
  • 1R34MH100317-01 (U.S. NIH-bevilling/kontrakt)

Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .

Kliniske forsøg med Cognitive remediation

Abonner